Chorioamnionitis is associated with increased CD40L expression on cord blood platelets

Thrombosis and Haemostasis

Volumn 94, Issue 6, 2005, Pages 1219-1223

  Sitaru, Ana Gabriela ^a   Speer, Christian P ^a   Holzhauer, Susanne ^a   Obergfell, Achim ^a   Walter, Ulrich ^a   Grossmann, Ralf ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

CD40L; Chorioamnionitis; Neonates; Platelets

Indexed keywords

ANTIBIOTIC AGENT; CD40 LIGAND; INTERLEUKIN 6; PADGEM PROTEIN;

ADULT; ARTICLE; CHORIOAMNIONITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; INFLAMMATION; MALE; NEWBORN; PATHOGENESIS; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; THROMBOCYTE; UMBILICAL CORD BLOOD;

BLOOD PLATELETS; CD40 LIGAND; CHORIOAMNIONITIS; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INTERLEUKIN-6; LEUKOCYTE COUNT; P-SELECTIN; PREGNANCY; PREMATURE BIRTH;

EID: 29244447667     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-02-0127     Document Type: Article

References (30)

1. Dexter SC, Pinar H, Malee MP et al. Outcome of very low birth weight infants with histopathologic chorioamnionitis. Obstet Gynecol 2000; 96: 172-7.
2. Jobe AH, Ikegami M. Antenatal infection/inflammation and postnatal lung maturation and injury. Respir Res 2001; 2: 27-32.
3. Bracci R, Buonocore G. Chorioamnionitis: a risk factor for fetal and neonatal morbidity. Biol Neonate 2003; 83: 85-96.
4. Williams MC, O'Brien WF, Nelson RN et al. Histologic chorioamnionitis is associated with fetal growth restriction in term and preterm infants. Am J Obstet Gynecol 2000; 183: 1094-9.
5. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. Jama 1997; 278: 207-11.
6. Nelson KB, Willoughby RE. Infection, inflammation and the risk of cerebral palsy. Curr Opin Neurol 2000; 13: 133-9.
7. Watterberg KL, Demers LM, Scott SM et al. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97: 210-5.
8. Speer CP. Inflammation and bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 29-38.
9. Dollner H, Vatten L, Halgunset J et al. Histologic chorioamnionitis and umbilical serum levels of pro-inflammatory cytokines and cytokine inhibitors. Bjog 2002; 109: 534-9.
10. Grable IA, Heine RP. Neutrophil granule products: can they identify subclinical chorioamnionitis in patients with preterm premature rupture of membranes? Am J Obstet Gynecol 2003; 189: 808-12.
11. Speer CP. Pre- and postnatal inflammatory mechanisms in chronic lung disease of preterm infants. Paediatr Respir Rev 2004; 5 Suppl A: S241-4.
12. Craven CM, Ward K. Fetal endothelial cells express vascular cell adhesion molecule in the setting of chorioamnionitis. Am J Reprod Immunol 2000; 43: 259-63.
13. D'Alquen D, Kramer BW, Seidenspinner S et al. Activation of umbilical cord endothelial cells and fetal inflammatory response in preterm infants with chorioamnoinitis and funisitis. Pediatr Res 2005; 57: 263-9.
14. McIntyre TM, Prescott SM, Weyrich AS et al. Cell-cell interactions: leukocyte-endothelial interactions. Curr Opin Hematol 2003; 10: 154-8.
15. Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemost 2003; 1: 1897-905.
16. Bancalari E, Abdenour GE, Feller R et al. Broncho-pulmonary dysplasia: clinical presentation. J Pediatr 1979; 95: 819-23.
17. Li N, Hu H, Lindqvist M et al. Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol 2000; 20: 2702-8.
18. Elzey BD, Tian J, Jensen RJ et al. Platelet-mediated modulation of adaptive immunitv. A communication link between innate and adaptive immune compartments. Immunity 2003; 19: 9-19.
19. Danese S, de la Motte C, Rivera Reyes BM et al. T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. J Immunol 2004; 172: 2011-15.
20. Pfeiffer KA, Reinsberg J, Rahmun A et al. Clinical application of maternal serum cytokine determination in premature rupture of membranes-interleukin-6, an early predictor of neonatal infection? Acta Obstet Gynecol Scand 1999; 78: 774-8.
21. Stallmach T. Cytokine production. Lab Invest 1995; 73: 384-92.
22. Chaiworapongsa T, Romero R, Kim JC et al. Evidence for fetal involvement in the pathologic process of clinical chorioamnionitis. Am J Obstet Gynecol 2002; 186: 1178-82.
23. Spangenberg P, Redlich H, Bergmann I et al. The platelet glycoprotein IIb/IIIa complex is involved in the adhesion of activated platelets to leukocytes. Thromb Haemost 1993; 70: 514-21.
24. Sitaru AG, Holzhauer S, Speer CP et al. Neonatal platelets: are they different? Platelets 2005; 16: 203-10.
25. Henn V, Steinbach S, Buchner K et al. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001; 98: 1047-54.
26. Weber AA, Hermann A, Rauch BH et al. Molecular identity of platelet CD40 Ligand (CD40L). Thromb Haemost (abstr) 2001; 86: 718.
27. Furman MI, Krueger LA, Linden MD et al. Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization. J Am Coll Cardiol 2004; 43: 2319-25.
28. Otterdal K, Pedersen TM, Solum NO. Release of soluble CD40 ligand after platelet activation: studies on the solubilization phase. Thromb Res 2004; 114: 167-77.
29. Hermann A, Rauch BH, Braun M et al. Platelet CD40 ligand (CD40L) - subcellular localization, regulation of expresion, and inhibition by clopidogrel. Platelets 2001; 12: 74-82.
30. Zaretsky MV, Alexander JM, Byrd W et al. Transfer of inflammatory cytokines across the placenta. Obstet Gynecol 2004; 103: 546-50.